GlassScriptPhysician profile
Stephenie C Jackson
NPI 1427722917
$1,180.74
in general payments reported to CMS, 2019-2025
11 companies · $56.58 in 2025
The $56.58 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $444 · 2023: $472 · 2024: $209 · 2025: $56.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.15 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $288.98 | 2022-2023 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $220.71 | 2022 | |
| Alkermes, INC. | $161.92 | 2024 | Lybalvi, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $151.13 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $109.24 | 2022 | |
| Janssen Pharmaceuticals, INC | $99.99 | 2023 | Invega Sustenna |
| Hologic Sales and Service, LLC | $45.54 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| E.R. Squibb & Sons, L.L.C. | $40.79 | 2025 | Cobenfy |
| Gilead Sciences, INC. | $25.66 | 2024 | |
| Indivior INC. | $20.99 | 2022 | |
| Novo Nordisk INC | $15.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephenie Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.